These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15781080)

  • 1. Breast cancer metastasis: when, where, how?
    Eccles SA; Paon L
    Lancet; 2005 Mar 19-25; 365(9464):1006-7. PubMed ID: 15781080
    [No Abstract]   [Full Text] [Related]  

  • 2. The differences in CXCR4 protein expression are significant for the five molecular subtypes of breast cancer.
    Zhang M; Liu HX; Teng XD; Wang HB; Cui J; Jia SS; Gu XY; Li ZG
    Ultrastruct Pathol; 2012 Dec; 36(6):381-6. PubMed ID: 23216236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER-2-negative breast cancer limitations and next-generation sequencing technology promises.
    Baltogiannis G; Katsios C; Zografos GC; Roukos DH
    Ann Surg Oncol; 2010 Jun; 17(6):1720. PubMed ID: 20198443
    [No Abstract]   [Full Text] [Related]  

  • 4. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer.
    Cabioglu N; Yazici MS; Arun B; Broglio KR; Hortobagyi GN; Price JE; Sahin A
    Clin Cancer Res; 2005 Aug; 11(16):5686-93. PubMed ID: 16115904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new path to the cancer epigenome.
    Richon VM
    Nat Biotechnol; 2008 Jun; 26(6):655-6. PubMed ID: 18536689
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation does not always show a causal relationship.
    Buyukhatipoglu H; Homaei-Shandiz F
    Saudi Med J; 2007 Jun; 28(6):986; author reply 986. PubMed ID: 17530133
    [No Abstract]   [Full Text] [Related]  

  • 7. High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.
    Chu QD; Panu L; Holm NT; Li BD; Johnson LW; Zhang S
    J Surg Res; 2010 Apr; 159(2):689-95. PubMed ID: 19500800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
    Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
    J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
    Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
    Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
    Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
    Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
    Woo SU; Bae JW; Kim CH; Lee JB; Koo BW
    Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modern pathologic diagnostics in breast cancer].
    Szoke J; Udvarhelyi N
    Orv Hetil; 2012 Jan; 153(1):22-30. PubMed ID: 22204831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2/neu diagnostics in breast cancer.
    Carney WP; Leitzel K; Ali S; Neumann R; Lipton A
    Breast Cancer Res; 2007; 9(3):207. PubMed ID: 17561991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions.
    Davidson B; Dong HP; Holth A; Berner A; Risberg B
    Breast J; 2008; 14(5):476-82. PubMed ID: 18657145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER-2/neu expression in primary and metastatic breast cancer.
    Lower EE; Glass E; Blau R; Harman S
    Breast Cancer Res Treat; 2009 Jan; 113(2):301-6. PubMed ID: 18273700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of breast cancer in young women: prognosis and prognostic factors.
    Saito E
    Nihon Geka Hokan; 1996 Nov; 65(4):133-44. PubMed ID: 9528272
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular prognostic factors for breast cancer metastasis and survival.
    Esteva FJ; Sahin AA; Cristofanilli M; Arun B; Hortobagyi GN
    Semin Radiat Oncol; 2002 Oct; 12(4):319-28. PubMed ID: 12382190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
    Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
    Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Minimal breast cancer: some prognostic signs].
    Ermachenkova AM
    Vopr Onkol; 2013; 59(3):299-301. PubMed ID: 23909029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.